Preferred Label : Glasdegib Maleate;
NCIt synonyms : PF 04449913 Maleate; 1-((2R,4R)-2-(1H-Benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea
Maleate;
NCIt definition : The maleate salt form of glasdegib, an orally bioavailable small-molecule, smoothened
(SMO) receptor inhibitor, with potential antineoplastic activity. Upon oral administration,
glasdegib targets, binds to and inhibits the activity of SMO. This inhibits the activity
of the Hedgehog (Hh) signaling pathway and inhibits the growth of tumor cells in which
this pathway is aberrantly activated. SMO, a transmembrane protein, is involved in
Hh signal transduction. The Hh signaling pathway plays an important role in cellular
growth, differentiation, repair, and cancer stem cell (CSC) survival. Constitutive
activation of Hh pathway signaling has been observed in various types of malignancies
and is associated with uncontrolled cellular proliferation in a variety of cancers.;
UNII : TH2EV99S4Z;
CAS number : 2030410-25-2; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2030410-25-2
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Drug name : Daurismo;
NCI Metathesaurus CUI : CL935991;
Origin ID : C156894;
UMLS CUI : C4741340;
- Semantic type(s)
- concept_is_in_subset
- has_free_acid_or_base_form
- has_target
- is_component_of_chemotherapy_regimen
- is_salt_form_of
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/daurismo-5332.html
2020
false
false
false
Canada
French
drug evaluation
Glasdegib
Glasdegib Maleate
glasdegib
glasdegib
benzimidazoles
phenylurea compounds
---
https://www.ema.europa.eu/en/medicines/human/EPAR/daurismo
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Glasdegib
Glasdegib
benzimidazoles
benzimidazoles
phenylurea compounds
phenylurea compounds
glasdegib
antineoplastic agents
antineoplastic agents
adult
aged
antineoplastic combined chemotherapy protocols
cytarabine
leukemia, myeloid, acute
orphan drug production
administration, oral
SMO protein, human
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Glasdegib Maleate
Glasdegib Maleate
glasdegib
glasdegib
Smoothened Receptor
receptors, g-protein-coupled
---